Literature DB >> 26393331

Analytical evaluation of a second generation assay for chromogranin A; a dual-site study.

Johannes G Krabbe, Phillip J Monaghan, Joanne Russell, Yolanda B de Rijke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26393331     DOI： 10.1515/cclm-2015-0782

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  3 in total

1.  Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival.

Authors:  Christian Niedworok; Stephan Tschirdewahn; Henning Reis; Nils Lehmann; Miklós Szücs; Péter Nyirády; Imre Romics; Herbert Rübben; Tibor Szarvas
Journal:  Pathol Oncol Res       Date:  2016-12-23       Impact factor: 3.201

2.  High-soluble CGA levels are associated with poor survival in bladder cancer.

Authors:  T Szarvas; B Jardin-Watelet; N Bourgoin; M J Hoffmann; P Nyirády; C Oláh; T Széll; A Csizmarik; B Hadaschik; H Reis
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

3.  Comparison of two chromogranin A assays and investigation of nonlinear specimens.

Authors:  J Alan Erickson; Fang-I Chiang; Chelsie M Walker; Jonathan R Genzen; Kelly Doyle
Journal:  Pract Lab Med       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.